Quality Assurance for NGS in Molecular Pathology Diagnostics

Quality Assurance for NGS in Molecular Pathology Diagnostics

Dr. Sabine Merkelbach-Bruse, PhD, Head of the Molecular Pathology Diagnostic Lab, University Clinic Cologne
Topic: Cancer Genomics

Discover the steps that have been taken to implement next-generation sequencing (NGS) into the clinical molecular pathology diagnostic laboratory to receive an accreditation from Germany’s national accreditation body (DAkkS). Obtain unique insights that have the potential to reduce your cost and time to establish NGS in your lab.



Introducing Nextera™ Flex for Enrichment
Grace DeSantis, Ph.D. Director, Product Development, Illumina, Inc.
Topic: Cancer Genomics : Human Genetics & Genetic Disease
IASLC 2019 Targeted Therapies of Lung Cancer Meeting
Santa Monica, CA | North America
Topic: Cancer Genomics
Advances in Genome Biology and Technology (AGBT) Annual Meeting 2019
Marco Island, FL | North America
Topic: Agriculture Genomics : Cancer Genomics : Forensic Genomics : Reproductive & Genetic Health : Human Genetics & Genetic Disease : Microbiology & Infectious Disease : HLA Typing